Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats

BACKGROUND: The present study evaluated the therapeutic effectiveness of moxidectin 1.0% (w/v) and imidacloprid 10% (w/v) (Advocate® spot-on solution for cats, Bayer Animal Health) against natural infections with the eyeworm Thelazia callipaeda in cats. This study was conducted as a GCP, negative-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Otranto, Domenico, Solari Basano, Fabrizio, Pombi, Marco, Capelli, Gioia, Nazzari, Roberto, Falsone, Luigi, Petry, Gabriele, Pollmeier, Matthias Günter, Lia, Riccardo Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329153/
https://www.ncbi.nlm.nih.gov/pubmed/30635002
http://dx.doi.org/10.1186/s13071-018-3262-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329153/
https://www.ncbi.nlm.nih.gov/pubmed/30635002
http://dx.doi.org/10.1186/s13071-018-3262-1

Ejemplares similares